South Africa Starts Using Lenacapavir to Prevent HIV
南非開始使用 Lenacapavir 預防 HIV
Introduction
The South African government has started distributing lenacapavir, a long-acting injection designed to prevent HIV infection.
南非政府已開始分發 lenacapavir，這是一種旨在預防 HIV 感染的長效注射藥物。
Main Body
The use of lenacapavir follows clinical trials in South Africa and Uganda, where results showed that the six-month injection was 100% effective. Developed by Gilead Sciences, this medication provides an alternative to taking pills every day. A $29 million grant from the Global Fund helped purchase the first doses for 456,000 people, although the government plans to find its own funding and other donors in the future.
使用 lenacapavir 是基於在南非和烏干達進行的臨床試驗，結果顯示這種每半年一次的注射藥物具有 100% 的療效。這款由 Gilead Sciences 開發的藥物，為不想每天服用藥丸的人提供了替代方案。全球基金（Global Fund）提供了 2,900 萬美元的撥款，協助為 456,000 人購買首批藥劑，不過政府計劃未來將尋找自有資金及其他捐助者。
However, there are disagreements about how many doses are needed. While President Cyril Ramaphosa stated that he wants to reach 3 million people within three years, community organizations argue that at least 2 million doses per year are necessary to significantly lower infection rates. Furthermore, the African Alliance emphasized that there is a gap between South Africa's help with the research and how easily people can actually get the drug.
然而，關於需要多少劑量仍存在分歧。雖然總統 Cyril Ramaphosa 表示希望在三年內覆蓋 300 萬人，但社區組織認為每年至少需要 200 萬劑，才能顯著降低感染率。此外，非洲聯盟（African Alliance）強調，南非在研究方面的協助與民眾實際獲取藥物的便捷程度之間存在差距。
To lower costs, Health Minister Aaron Motsoaledi explained that Gilead Sciences has agreed to a voluntary license. This means generic versions can be made locally, which will reduce the annual cost per person from $28,000 to just $40. Currently, nearly 38,000 doses are being distributed across 360 facilities in six provinces, focusing on high-risk groups such as sex workers and adolescent women. Unfortunately, the closure of 12 specialized clinics due to the end of U.S. aid has created logistical problems, as advocates worry that moving patients to state facilities may reduce privacy and effectiveness.
為了降低成本，衛生部長 Aaron Motsoaledi 解釋說 Gilead Sciences 已同意自願授權。這意味著可以在本地生產通用藥版本，將每人每年的成本從 28,000 美元降低至僅 40 美元。目前，近 38,000 劑藥正分發至六個省的 360 個機構，重點對象為性工作者和青少年女性等高風險群體。不幸的是，由於美國援助結束導致 12 家專科診所關閉，造成了物流問題，倡導者擔心將患者轉至國家設施可能會降低私隱保障和療效。
Conclusion
South Africa has begun rolling out a highly effective HIV preventative injection, but challenges regarding the number of doses and clinic access remain.
南非已開始推行一種高效的 HIV 預防注射藥物，但關於劑量數量和診所獲取渠道的挑戰依然存在。
Vocabulary Learning
⚡ The 'B2 Logic' Shift: Moving Beyond Simple Sentences
At the A2 level, you likely say: "The drug is expensive. Now it is cheap." To reach B2, you need to connect ideas using Contrast and Concession. This allows you to describe a complex situation in one breath.
🛠️ The Tool: The 'However' vs. 'Although' Pivot
Look at these two patterns from the text:
1. The Heavy Pause (However)
"...the government plans to find its own funding... However, there are disagreements..."
Use this when: You want to stop the first thought completely and start a new, opposing one. It is a 'brick wall' that changes the direction of the conversation.
2. The Smooth Blend (Although)
"...although the government plans to find its own funding..."
Use this when: You want to acknowledge a fact but show that it doesn't stop the main point. It makes your English sound more fluid and professional.
🚀 Level-Up: From 'Bad' to 'Logistical Problems'
B2 students stop using general words (good, bad, big, small) and use Specific Nouns.
| A2 Word (General) | B2 Word (Precise) | Context from Article |
|---|---|---|
| Problems | Logistical problems | Issues with moving patients/buildings |
| Difference | A gap | The space between research and access |
| Way/Choice | Alternative | A different option to taking pills |
💡 Pro-Tip: The 'Passive' Power-Up
Notice the phrase: "generic versions can be made locally".
Instead of saying "Companies can make generic versions", the writer puts the object (the medicine) first. Why? Because in B2 academic English, the action is more important than who is doing it.